CANADA LIFE ASSURANCE Co Increases Position in HCA Healthcare, Inc. (NYSE:HCA)

CANADA LIFE ASSURANCE Co raised its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 1.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 188,971 shares of the company's stock after acquiring an additional 2,462 shares during the quarter. CANADA LIFE ASSURANCE Co owned approximately 0.07% of HCA Healthcare worth $56,726,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. Whipplewood Advisors LLC purchased a new position in shares of HCA Healthcare during the fourth quarter valued at approximately $31,000. Tidemark LLC purchased a new stake in shares of HCA Healthcare in the 4th quarter worth about $36,000. Activest Wealth Management increased its position in shares of HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after buying an additional 125 shares during the period. Pinnacle Bancorp Inc. boosted its position in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after acquiring an additional 50 shares in the last quarter. Finally, Eastern Bank purchased a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $62,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.30% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

HCA has been the subject of several recent research reports. Cantor Fitzgerald reissued an "overweight" rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Truist Financial dropped their price target on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Guggenheim initiated coverage on HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating on the stock. Royal Bank of Canada reduced their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research note on Monday, January 27th. Finally, KeyCorp cut their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $381.67.

HCA Healthcare Price Performance

NYSE:HCA traded up $9.36 on Wednesday, reaching $333.98. 552,541 shares of the company's stock traded hands, compared to its average volume of 1,383,357. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market cap of $82.23 billion, a PE ratio of 15.20, a P/E/G ratio of 1.10 and a beta of 1.48. The stock has a 50-day simple moving average of $328.71 and a 200-day simple moving average of $333.13.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the company posted $5.90 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 31st. Investors of record on Monday, March 17th were given a $0.72 dividend. The ex-dividend date of this dividend was Monday, March 17th. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. HCA Healthcare's dividend payout ratio (DPR) is currently 13.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.